Jacques Näsström

No open positions remaining

67 year

Health Technology

Consumer Services

Commercial Services

Profile

Jacques Näsström worked as the Chief Executive Officer at Accuro Immunology AB. He then served as the Director of Cellular & Molecular Pharmacology at Astra AB from 1986 to 2001.
Dr. Näsström also held the position of Director at Cellectricon AB. From 2006 to 2010, he worked as the Research Director at Q-Med AB. He was also the Director at Independent Pharmaceutica AB. Prior to that, Dr. Näsström worked as an Investment Manager at Karolinska Investment Fund KB from 2001 to 2006.
He also served as the Principal at AngioGenetics AB. Currently, he is the Chief Scientific Officer & Vice President at Egetis Therapeutics AB, a position he has held since 2017.
In terms of education, Dr. Näsström holds an MBA from Stockholm School of Economics and a doctorate from the University of Uppsala.

Former positions of Jacques Näsström

Companies	Position	End
EGETIS THERAPEUTICS AB	Chief Executive Officer	16/06/2017
Q-Med AB Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use	Chief Tech/Sci/R&D Officer	01/01/2010
Karolinska Investment Fund KB Karolinska Investment Fund KB Investment ManagersFinance Acts as Venture Capital Fund	Chief Investment Officer	-
Astra AB Astra AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals preparations	Corporate Officer/Principal	01/01/2001
AngioGenetics AB AngioGenetics AB Pharmaceuticals: GenericHealth Technology Develops, markets, and distributes generic drugs	Corporate Officer/Principal	-

See the detail of Jacques Näsström's experience

Training of Jacques Näsström

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jacques Näsström's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Astra AB Astra AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals preparations	Health Technology
Cellectricon AB Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery	Commercial Services
Q-Med AB Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use	Health Technology
Stockholm School of Economics Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Accuro Immunology AB Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Develops and manufactures active immunotherapy products	Health Technology
Karolinska Investment Fund KB Karolinska Investment Fund KB Investment ManagersFinance Acts as Venture Capital Fund	Finance
AngioGenetics AB AngioGenetics AB Pharmaceuticals: GenericHealth Technology Develops, markets, and distributes generic drugs	Health Technology
Independent Pharmaceutica AB Independent Pharmaceutica AB Medical DistributorsDistribution Services Provides pharmacological solutions for treatment of nicotine addiction.	Distribution Services
Egetis Therapeutics AB Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology